1. Home
  2. PACS vs BIO Comparison

PACS vs BIO Comparison

Compare PACS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PACS Group Inc.

PACS

PACS Group Inc.

HOLD

Current Price

$44.48

Market Cap

7.7B

Sector

N/A

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$359.00

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACS
BIO
Founded
2013
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.0B
IPO Year
2024
1994

Fundamental Metrics

Financial Performance
Metric
PACS
BIO
Price
$44.48
$359.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$45.50
$339.75
AVG Volume (30 Days)
879.2K
293.3K
Earning Date
02-26-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
221.05
142.61
EPS
0.97
N/A
Revenue
$5,288,932,000.00
$2,583,200,000.00
Revenue This Year
$10.19
$2.74
Revenue Next Year
$8.58
$3.20
P/E Ratio
$46.39
N/A
Revenue Growth
29.32
0.65
52 Week Low
$7.50
$236.73
52 Week High
$49.49
$365.00

Technical Indicators

Market Signals
Indicator
PACS
BIO
Relative Strength Index (RSI) 45.75 76.07
Support Level $43.00 $289.16
Resistance Level $47.79 N/A
Average True Range (ATR) 2.56 11.71
MACD -0.47 2.26
Stochastic Oscillator 45.95 91.52

Price Performance

Historical Comparison
PACS
BIO

About PACS PACS Group Inc.

PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: